Skip to main content

Rowe Jeffrey M's Form 4 filing

Zomedica Corp. (ZOMDF) · filed Mar 18, 2025

Accession no.
0001654954-25-002968
Filed
Mar 18, 2025, 4:52 PM ET
Trade date
Mar 17, 2025
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 6 non-derivative transactions. Open-market purchases total $96.1K. It was filed 1 day after the trade.

This filing was later replaced by the amendment 0001654954-25-003382 (Mar 27, 2025). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rowe Jeffrey MCIK 0001619009Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 17, 2025Common Stock, without par valuePPurchaseAcquired+500,000$0.064+$32,000775,000Indirect
Mar 17, 2025Common Stock, without par valuePPurchaseAcquired+100,647$0.07+$7,045.29875,647Indirect
Mar 17, 2025Common Stock, without par valuePPurchaseAcquired+68,000$0.067+$4,556943,647Indirect
Mar 17, 2025Common Stock, without par valuePPurchaseAcquired+731,368$0.068+$49,733.021,675,015Indirect
Mar 17, 2025Common Stock, without par valuePPurchaseAcquired+4,265$0.07+$298.551,679,280Indirect
Mar 17, 2025Common Stock, without par valuePPurchaseAcquired+34,725$0.071+$2,465.481,714,005Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)